Skip to content

Association Between Vitamin D Receptor Polymorphism and Serum Vitamin D Levels in Children With Low-Energy Fractures

Association Between Vitamin D Receptor Polymorphism and Serum Vitamin D Levels in Children With Low-Energy Fractures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02805647
Enrollment
222
Registered
2016-06-20
Start date
2011-01-31
Completion date
2016-01-31
Last updated
2019-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Receptor Defect

Keywords

25-Hydroxy-vitamin D, children, bone fractures, vitamin D receptor polymorphism

Brief summary

This study was designed to determine the impact of vitamin D serum levels and vitamin D receptor (VDR) polymorphisms on the occurrence of low energy fractures in children.

Detailed description

The study group consisted of 100 children aged 3 to 18 years (78% boys) hospitalized in the Department of Pediatric Orthopedics in 2011-2013 due to low-energy fractures. The control group (122 children, 68% boys) consisted of children aged 3 to 17 years, hospitalized for other reasons (injuries, diagnosis of knee ligament injuries and others) without fractures. Children with osteogenesis imperfecta (OI) were excluded from the study. From each patient and their parent/guardian a written informed consent to participate in the study was obtained. Low-energy fracture was defined as a fracture sustained from a fall from the patient's own height or a fall during team games. All fractures were radiologically confirmed. During hospitalization the patients and their parents completed a questionnaire on demographic data, the place of residence (urban/rural), earlier fractures and physical activity. The degree of sexual maturity was assessed using a survey of puberty development on the basis of Puberty Development Scale \[20-22\]. The patients' body weights and heights were measured, and the Cole indicator was calculated to assess the nutritional status of the patients. Serum concentrations of total vitamin D \[25-hydroxy vitamin D3 ((25(OH)D3)) plus 25-hydroxy vitamin D2 ((25(OH)D2))\] in the plasma of all the children were determined by electrochemiluminescence using paramagnetic particles coated with streptavidin and ruthenium compound on the Cobas e 411 apparatus by Roche. According to our laboratory, the reference value range for total vitamin D was 30.0 - 74.0 ng/ml.Whole blood samples were collected in tubes containing EDTA and stored at -20°C. DNA was isolated using the MasterPureTM DNA Purification Kit (Akor Laboratories) and quantified on a spectrophotometer (Nanodrop 2000, Thermo Scientific). The genotypes for four restriction fragment length polymorphisms of the vitamin D receptor (VDR) gene were determined by standard polymerase chain reaction (PCR) techniques and enzymatic digestion of the products with FokI, ApaI, TaqI and BsmI (Thermo Scientific). In short, PCR were performed in a final volume of 20 µl containing 50-100 ng DNA, 0.3 µM of each primer and JumpStartTM REDTaqTM ReadyMixTM (Sigma). After initial denaturation for 3 min at 94 °C, samples were subjected to 35 cycles of amplification, consisting of a 30-sec denaturing phase at 94 °C, a 30-sec annealing phase (FokI at 60 °C, ApaI and TaqI at 70 °C, BsmI at 62 °C), a 30-s extension phase at 72 °C, and 4-min at 72 °C on a Bio-Rad thermal cycler CFX96TM. The primers used for FokI polymorphism were: forward 5'-AGC TGG CCC TGG CAC TGA CTC TGC TCT-3', reverse 5'-ATG GAA ACA CCT TGC TTC TTC TCC CTC-3'; ApaI and TaqI: forward 5'-CAG AGC ATG GAC AGG GAG CAA-3', reverse 5'-GCA ACT CCT CAT GGC TGA GGT CTC-3' and BsmI: forward 5'-AGT GTG CAG GCG ATT CGT AG-3', reverse 5'-ATA GGC AGA ACC ATC TCT CAG-3' \[25\]. The PCR products were digested according to the manufacturer's instructions and separated on 2% agarose gel. The polymorphisms were documented by photographing under UV illumination using G:Box (Syngene). A random subset (20% of samples) was repeated to verify the results. Upper case letters F, A, T and B indicate the absence of the cut site for FokI, ApaI, TaqI and BsmI polymorphisms, respectively, whereas lower case letters f, a, t, and b indicate its presence.To examine the relationships between quality attributes Chi-square test of independence and Fisher's exact test were used. The normality of distribution was verified using the Kolmogorov-Smirnov test with the Lilliefors significance correction and the Shapiro-Wilk test. There was no normal distribution of quantitative variables analyzed. To compare the quantitative variables without normal distribution a nonparametric Mann - Whitney U test was used. Models of uni-variate and multi-variate linear regression and logistic regression were established. Results were considered statistically significant at p \<0.05. The calculations were performed using Statistica 10.0 by StatSoft, IBM SPSS Statistics 21.0 by Predictive Solutions Company and Stata / IC 13.1 packages by StataCorp LP

Interventions

None listed

Sponsors

American Medical Holdings Inc., Staten Island, NY 10314 USA
CollaboratorUNKNOWN
School of Pharmacy, Creighton University, Omaha, NE 68178 USA
CollaboratorUNKNOWN
Medical University of Bialystok
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* low-energy fractures. * healthy children hospitalized for other reasons than fractures (injuries, diagnosis of knee ligament injuries and others) without fractures

Exclusion criteria

* Children with osteogenesis imperfecta (OI) were excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Vitamin D Status; VDR StatusWe measured Vitamin D status at the time of admission - at the time of fractureSerum concentrations of total vitamin D; VDR polymorphism test

Countries

Poland

Participant flow

Recruitment details

Children with low energy fractures

Pre-assignment details

without bone diseases such as OI

Participants by arm

ArmCount
Fracture/Study Group
The study group consisted of 100 children aged 3 to 18 years (78% boys) hospitalized in the Department of Pediatric Orthopedics in 2011-2013 due to low-energy fractures
100
Control Group
The control group (122 children, 68% boys) consisted of children aged 3 to 17 years, hospitalized for other reasons (injuries, diagnosis of knee ligament injuries and others) without fractures
122
Total222

Baseline characteristics

CharacteristicControl GroupTotalFracture/Study Group
Age, Categorical
<=18 years
122 Participants222 Participants100 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous13 years
STANDARD_DEVIATION 2
13 years
STANDARD_DEVIATION 2
13 years
STANDARD_DEVIATION 2
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Poland
122 participants222 participants100 participants
Sex: Female, Male
Female
39 Participants61 Participants22 Participants
Sex: Female, Male
Male
83 Participants161 Participants78 Participants
Total vitamin D [25(OH)D3 plus 25(OH)D2] serum concentrations were evaluated in every patient. Genot17.49 ng/ml
STANDARD_DEVIATION 16
15 ng/ml
STANDARD_DEVIATION 14
13.81 ng/ml
STANDARD_DEVIATION 12

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1000 / 122
serious
Total, serious adverse events
0 / 1000 / 122

Outcome results

Primary

Vitamin D Status; VDR Status

Serum concentrations of total vitamin D; VDR polymorphism test

Time frame: We measured Vitamin D status at the time of admission - at the time of fracture

Population: Children from Poland Podlasie region

ArmMeasureValue (MEAN)
Fracture/Study GroupVitamin D Status; VDR Status13.81 ng/ml
Control GroupVitamin D Status; VDR Status17.49 ng/ml

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026